Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/acetaminophen vs prolonged-release oxycodone for bone metastasis cancer pain
ChiCTR2500101653Phase 4Not yet recruiting
- Sponsor
- Quzhou People's Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oxycodone and acetaminophen in bone metastases (2 arms), sponsored by Quzhou People's Hospital. Primary endpoint: Pain relief at 14 days. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
oxycodoneacetaminophen
03
Conditions
bone metastases
Beyond the preview
Go deeper on ChiCTR2500101653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101653.